Bioptigen, Inc. (Bioptigen) is a provider of optical instruments and lenses. The company is engaged in the development of innovative in vivo optical imaging systems for biomedical applications. In vivo optical imaging systems enable real-time non invasive imaging of internal tissue microstructure, advancing critical applications in drug development, tissue engineering, genetics research and medical vision. The company offers 3D SDOCT systems for biotech, ophthalmic, clinical research and pre-clinical pharma applications. Its product line includes clinical scanners, hand-held probes, optical coherence tomography (OCT) microscopes, OSDR engines and software for structural and functional OCT imaging. Bioptigen develops and commercializes its products based on the technology of OCT, an imaging system similar in function to ultrasound, but rather uses low-power light rather than sound waves. It is a spin-out of the Duke University Biomedical Engineering Department. Bioptigen is headquartered in North Carolina, the US.